Back to Trades
King-Jones Heidy
See RemarksCIK 0001794898
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, King-Jones Heidy, See Remarks, has disclosed $4.3M in transactions — all concentrated in Spyre Therapeutics, Inc. (SYRE). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Jan 13 | SYRE Spyre Therapeutics, Inc. | King-Jones Heidy | See Remarks | Award | $4.3M |
1 filing